• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症的死亡率:与普通人群的比较。

Mortality in systemic sclerosis: a comparison with the general population.

作者信息

Abu-Shakra M, Lee P

机构信息

University of Toronto Rheumatic Disease Unit, Wellesley Hospital, Canada.

出版信息

J Rheumatol. 1995 Nov;22(11):2100-2.

PMID:8596151
Abstract

OBJECTIVE

To compare the mortality rate in patients with systemic sclerosis (SSc) with that of the general population.

METHODS

Standardized mortality ratios (SMR) were calculated for 237 patients with SSc followed prospectively, using age and sex specific mortality rates in Ontario for the period 1976-1990.

RESULTS

The overall SMR for the SSc cohort was 4.69. The mortality rate was greater with diffuse than with limited scleroderma (SMR 6.18 and 3.80, respectively), but not different between men and women.

CONCLUSION

The mortality rate in SSc is increased compared to that of the general population, especially in the subset with diffuse disease.

摘要

目的

比较系统性硬化症(SSc)患者的死亡率与普通人群的死亡率。

方法

对237例前瞻性随访的SSc患者计算标准化死亡率(SMR),采用1976 - 1990年安大略省特定年龄和性别的死亡率。

结果

SSc队列的总体SMR为4.69。弥漫性硬皮病的死亡率高于局限性硬皮病(SMR分别为6.18和3.80),但男女之间无差异。

结论

与普通人群相比,SSc患者的死亡率升高,尤其是在弥漫性疾病亚组中。

相似文献

1
Mortality in systemic sclerosis: a comparison with the general population.系统性硬化症的死亡率:与普通人群的比较。
J Rheumatol. 1995 Nov;22(11):2100-2.
2
Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.台湾系统性硬化症的流行病学和死亡率:一项全国性人群研究。
Scand J Rheumatol. 2011;40(5):373-8. doi: 10.3109/03009742.2011.553736. Epub 2011 Mar 9.
3
Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.临床特征、血清抗核抗体及肺功能对系统性硬化症患者生存率的影响。
J Rheumatol. 2001 Nov;28(11):2454-9.
4
Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis.安大略省西南部硬皮病患病率上升:一项聚类分析。
J Rheumatol. 2002 Sep;29(9):1867-73.
5
Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample.系统性硬化症的住院率和死亡率:来自全国住院患者样本的结果。
Rheumatology (Oxford). 2007 Dec;46(12):1808-13. doi: 10.1093/rheumatology/kem273. Epub 2007 Nov 6.
6
[Scleroderma--systemic sclerosis. Serology, lung function and survival].[硬皮病——系统性硬化症。血清学、肺功能与生存率]
Ugeskr Laeger. 1999 May 24;161(21):3084-90.
7
Predictors of survival and causes of death in Japanese patients with systemic sclerosis.日本系统性硬化症患者的生存预测因素和死亡原因。
J Rheumatol. 2011 Sep;38(9):1931-9. doi: 10.3899/jrheum.100298. Epub 2011 Jul 15.
8
Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.在未选择和完整的挪威系统性硬化症患者队列中,患者的生存和死因。
J Rheumatol. 2013 Jul;40(7):1127-33. doi: 10.3899/jrheum.121390. Epub 2013 May 1.
9
[Causes of death of patients with systemic sclerosis].[系统性硬化症患者的死因]
Pol Merkur Lekarski. 2006 Oct;21(124):341-4.
10
Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.无硬皮病的系统性硬化症:48例患者的人口统计学、临床和血清学特征及生存率
Arthritis Rheum. 2000 Feb;43(2):444-51. doi: 10.1002/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G.

引用本文的文献

1
Systemic sclerosis and risk of bronchiectasis: a nationwide longitudinal cohort study.系统性硬皮病与支气管扩张症风险:一项全国性纵向队列研究。
Arthritis Res Ther. 2023 Oct 23;25(1):209. doi: 10.1186/s13075-023-03189-2.
2
Standardized mortality ratios in systemic sclerosis: a meta-analysis assessing overall and sex- and disease subtype-specific differences.系统性硬化症的标准化死亡比:一项评估总体以及性别和疾病亚型特异性差异的荟萃分析。
Z Rheumatol. 2024 Feb;83(Suppl 1):175-182. doi: 10.1007/s00393-023-01401-x. Epub 2023 Aug 19.
3
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
系统性硬皮病合并或不合并间质性肺病的肺动脉高压的临床特征和生存情况。
Arthritis Res Ther. 2023 May 12;25(1):77. doi: 10.1186/s13075-023-03059-x.
4
Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.系统性硬化症的生存和预后因素:一项法国多中心队列研究、系统评价和文献荟萃分析的数据。
Arthritis Res Ther. 2019 Apr 3;21(1):86. doi: 10.1186/s13075-019-1867-1.
5
Overall and sex- and disease subtype-specific mortality in patients with systemic sclerosis : An updated meta-analysis.系统性硬化症患者的总体死亡率以及按性别和疾病亚型划分的死亡率:一项更新的荟萃分析。
Z Rheumatol. 2019 Mar;78(2):195-201. doi: 10.1007/s00393-018-0492-8.
6
Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction.射血分数保留的心力衰竭导致硬皮病和肺动脉高压患者生存率低。
Pulm Circ. 2017 Apr-Jun;7(2):409-420. doi: 10.1177/2045893217700438. Epub 2017 Mar 27.
7
Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study.营养不良是墨西哥系统性硬化症患者死亡的独立危险因素:一项队列研究。
Rheumatol Int. 2017 Jul;37(7):1101-1109. doi: 10.1007/s00296-017-3753-y. Epub 2017 May 29.
8
Hematopoietic stem cell transplantation for auto immune rheumatic diseases.自身免疫性风湿疾病的造血干细胞移植
World J Transplant. 2016 Mar 24;6(1):199-205. doi: 10.5500/wjt.v6.i1.199.
9
Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients.早发型与晚发型系统性硬化症:1037例患者的临床表现及预后差异
Medicine (Baltimore). 2014 Mar;93(2):73-81. doi: 10.1097/MD.0000000000000018.
10
Treatment of systemic sclerosis: potential role for stem cell transplantation.系统性硬化症的治疗:干细胞移植的潜在作用。
Stem Cells Cloning. 2009 Nov 18;2:1-9. doi: 10.2147/sccaa.s5282.